Skip to main content
Fig. 1 | Biological Research

Fig. 1

From: Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway

Fig. 1

The clinical effect of Betahistine on BPPV and the expression of multiple CTRP family members. BPPV patients were treated with Betahistine (12 mg/time, 3 times/day) for 4 weeks, and blood was collected and serum was separated. The duration of residual dizziness (A), DHI score (B) and BBS score (C) were recorded. The expression of CTRP1 (D), CTRP 3 (E), CTRP 6 (F), CTRP 9 (G) and CTRP 12 (H) in serum was detected by using ELISA. N = 5, tatistical differences were performed by using the Student’s t-test. Compared with BPPV patient, *P < 0.05, **P < 0.01

Back to article page

Biological Research

ISSN: 0717-6287

Contact us